Eli Lilly (LLY) Other Gross PP&E Adjustments (2016 - 2024)
Eli Lilly (LLY) has disclosed Other Gross PP&E Adjustments for 16 consecutive years, with $382.0 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Other Gross PP&E Adjustments rose 19.45% year-over-year to $382.0 million, compared with a TTM value of $382.0 million through Dec 2024, up 19.45%, and an annual FY2024 reading of $382.0 million, up 19.45% over the prior year.
- Other Gross PP&E Adjustments was $382.0 million for Q4 2024 at Eli Lilly, up from $319.8 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $382.0 million in Q4 2024 and bottomed at $226.8 million in Q4 2020.
- Average Other Gross PP&E Adjustments over 5 years is $288.8 million, with a median of $258.7 million recorded in 2021.
- The sharpest move saw Other Gross PP&E Adjustments surged 162.55% in 2020, then dropped 0.81% in 2022.
- Year by year, Other Gross PP&E Adjustments stood at $226.8 million in 2020, then rose by 14.07% to $258.7 million in 2021, then decreased by 0.81% to $256.6 million in 2022, then grew by 24.63% to $319.8 million in 2023, then grew by 19.45% to $382.0 million in 2024.
- Business Quant data shows Other Gross PP&E Adjustments for LLY at $382.0 million in Q4 2024, $319.8 million in Q4 2023, and $256.6 million in Q4 2022.